INSIGHT-Copy me: Europe shows U.S. a path to cheaper biotech drugs

LONDON/LOS ANGELES, March 6 (Reuters) - A revolution is brewing in healthcare with lower-cost copies of complex biotech drugs finally set to reach the United States, nine years after so-called biosimilars were launched in Europe.